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The health of the mother during pregnancy has consequences for the offspring in both the 8 
short and longer term.  Asthma is a common chronic respiratory disease that affects 4-12% 9 
of pregnant women globally and is associated with greater risk of pregnancy complications, 10 
such as preeclampsia, preterm delivery and fetal growth retardation.  Maternal asthma has 11 
also been linked to respiratory disorders in the neonate and childhood asthma (Mendola et 12 
al, 2014; Lui et al, 2018).   13 
Professor Clifton and colleagues in Australia have developed a sheep model of maternal 14 
allergic asthma to examine the consequences for fetal growth and development (Clifton et 15 
al, 2016).  Ewes were sensitized to house dust mite (HDM) allergens before conception and 16 
subsequently exposed to HDM allergens in airway challenges throughout gestation.  The 17 
respiratory system of HDM-exposed ewes showed pathophysiological changes resembling 18 
human asthma, including blood and lung eosinophil accumulation, thickening of airway 19 
smooth muscle, and increased lung resistance in response to HDM challenge.  In the fetuses 20 
during late gestation, body weight, expressed relative to maternal body weight, and 21 
pulmonary abundance of surfactant protein-B mRNA, were decreased. 22 
In this issue, the team present their latest findings on the development of the fetal lungs and 23 
immune system in the sheep model of maternal allergic asthma (Wooldridge et al, 2019).  24 
The density of type II pneumocytes, the alveolar cells that synthesize and secrete surfactant, 25 
in fetuses of HDM-exposed ewes was reduced by 30%.  Furthermore, the proportion of 26 
CD44+ lymphocytes present in the fetal thymus increased more than 3-fold, indicating 27 
activation of an immune response in utero.  The authors propose that these changes, if 28 
persistent, may predispose the offspring to respiratory and allergic diseases in postnatal life.  29 
Future studies will no doubt focus on longer term health outcomes in the neonate and adult 30 
offspring of HDM-exposed ewes.  In particular, it will be interesting to discover whether the 31 
impaired capacity for surfactant production in the fetal lungs affects lung compliance and 32 
respiratory function at birth.  The timing of the stages of lung maturation is similar in ovine 33 
and human fetuses which makes the sheep a relevant species to model the effects of 34 
maternal allergic asthma on lung development in utero.  Unlike clinical studies, these 35 
experiments can also differentiate between the effects of maternal asthma and those of 36 
medications used to treat the condition. 37 
The mechanisms responsible for mediating the effects of maternal allergic asthma on fetal 38 
growth and development are unclear and warrant further investigation.  Wooldridge et al 39 
(2019) found no evidence of HDM antibodies in the fetal circulation or an inflammatory 40 
response in the fetal lungs or amniotic fluid.  Other indicators of immune function in the 41 
ovine fetus remained unchanged, including the Th1/Th2 balance.  In pregnancies 42 
complicated by maternal asthma, placental development may be modified by chronic 43 
inflammation and hypoxic episodes, and in turn, impact the developing conceptus.  Changes 44 
in placental growth and vascular responsiveness, and expression of genes involved in 45 
placental metabolism, inflammation, oxidative stress and glucocorticoid bioavailability, have 46 
been reported in clinical studies of maternal asthma, in a manner often dependent on the 47 
sex of the offspring (Meakin et al, 2017).  Placental morphology was altered in the sheep 48 
model of maternal allergic asthma although the gross anatomy and ultrastructure of the 49 
ovine placenta is notably different to that of the human.   50 
Glucocorticoids are well-known to promote type II pneumocyte differentiation and 51 
surfactant production before birth, especially near term when concentrations rise in the 52 
fetal circulation.  No difference in plasma cortisol concentration was observed, however, 53 
between the offspring of HDM-exposed and control ewes, and concentrations were 54 
relatively low in both groups, indicating that the fetuses were not yet in the final stages of 55 
gestation.  Wooldridge et al (2019) suggest that maternal allergic asthma delays maturation 56 
of the fetal lungs, albeit independent of fetal cortisol, and propose that future studies 57 
examine the potential use of antenatal glucocorticoids to improve lung structure and 58 
function affected by maternal allergic asthma. 59 
Epigenetic modifications have been reported in blood cells at birth and at one year of age in 60 
children born to mothers with asthma (DeVries & Vercelli, 2017).  Several differentially 61 
methylated regions dependent on maternal asthma status were identified which may 62 
influence immune function in later life, including genes in pro-inflammatory and 63 
immunoregulatory pathways.  For example, in independent birth cohorts, hypermethylation 64 
of SMAD3 in cord blood mononuclear cells was observed in infants of asthmatic mothers 65 
who subsequently developed asthma.  SMAD3 is a transcription factor involved in tumour 66 
growth factor (TGF) signalling, and is therefore important for differentiation of both immune 67 
T-cells and type II pneumocytes and surfactant production.  The extent to which changes in 68 
SMAD3 and TGF signalling, via epigenetic mechanisms, contribute to the fetal sheep 69 
phenotype remains to be established.  70 
Collectively, findings from clinical studies and animal models highlight the importance of 71 
asthma control during pregnancy for normal growth and maturation of the offspring, and 72 
respiratory and immune function in later life.  Management of asthma in women of 73 
reproductive age may be equally important as the adverse consequences may arise at the 74 
time of conception.  The nature of the therapeutic approach may depend on the sex of the 75 
offspring: asthmatic women pregnant with a female fetus present a more severe 76 
inflammatory condition and impaired fetal growth, which can be corrected by inhaled 77 
glucocorticoid treatment, compared to those carrying a male fetus (Murphy et al, 2003).  78 
Pregnancy can alter the symptoms of asthma and, ironically, levels of non-compliance with 79 
asthma treatment increases during pregnancy in the mistaken belief that the medication 80 
may harm the unborn child.  Understanding the processes by which maternal asthma 81 
modifies development in utero will be essential to inform public health campaigns and the 82 
design of interventions to prevent neonatal respiratory disorders and combat the prevalence 83 
of asthma which may have origins in early life. 84 
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